This week we look at how energy insecurity and supply chain disruptions are affecting generic drug manufacturers in Europe. We also highlight new treatments for amyotrophic lateral sclerosis (ALS) and Alzheimer’s, as well as the challenges of starting vaccine trials in the midst of an Ebola outbreak. ... READ MORE >
Health Care
From hospital systems to home care providers, the health care sector is replete with middle market companies. The health needs of an aging population assure that this industry will continue to grow in coming years.
5 things to know in life sciences: Week of Sept. 19
This week, we look at another drug breaking the record for most expensive in the world, a complicated labor market with layoffs at many large pharmaceutical companies and expansions at others, and plans to build a quantum computer for life sciences research. We also look at GSK requiring various ... READ MORE >
5 things to know in life sciences: Week of Sept. 12
This week, we look at a new executive order encouraging biomanufacturing, a rare company going public through a special purpose acquisition company and what an executive can do when a trial is placed on a clinical hold. We also look at how progress in curing hepatitis C remains slow despite revolutionary ... READ MORE >
5 things to know in life sciences: Week of Aug. 29
This week we look at a cancer immunotherapy breakthrough that could strengthen chimeric antigen receptor T cells in their fight against liquid or solid tumors. We also highlight an unexpected special purpose acquisition company transaction revival, continued efforts to improve clinical trial diversity, ... READ MORE >
5 things to know in life sciences: Week of Aug. 22
This week we look at the challenges of scaling up monkeypox vaccine production to meet demand as the outbreak continues to grow globally. We also examine the large number of COVID-19 diagnostics, using real-world data to study pregnancy, and the promise of new stem cell studies coming from Japan. Finally, ... READ MORE >
Immigration is key to solving Canada’s labour shortage
There is no denying it: Canada is experiencing a historic labour shortage. The job market has been running hot for months, with the unemployment rate falling to 4.9%, the lowest on record. The pandemic and subsequent reopening have been the catalyst. At the onset of the pandemic, workers were laid ... READ MORE >
5 things to know in life sciences: Week of Aug. 15
This week, we look at the challenges of scaling up monkeypox vaccine production to meet demand as the outbreak continues to grow globally. We also look at a major spin-off of a clinical research organization, over-the-counter hearing aid sales, and one bright spot in the capital markets. Finally, we look ... READ MORE >
5 things to know in life sciences: Week of Aug. 8
This week, we highlight how the Inflation Reduction Act of 2022 could impact the U.S. biopharma industry. We also look at digitization in health care, the challenges facing researchers deploying the approved monkeypox vaccine, and a video on how COVID-19 evades the immune system. Finally, we look at what ... READ MORE >
5 things to know in life sciences: Week of Aug. 1, 2022
This week we highlight how big pharma is grappling with potential challenges surrounding drug pricing and the Inflation Reduction Act of 2022. We also look at Labcorp’s proposed spinoff of its clinical development business, progress toward the $100 genome, the return on investment of decentralized ... READ MORE >
5 things to know in life sciences: Week of July 25, 2022
This week we highlight a new enhanced COVID-19 vaccine trial and the spin out of another major health care business. We also look at a Food and Drug Administration clearance for the smallest blood clot removal device and a company that raised $192 million based on a heart-attack-predicting software ... READ MORE >